(Q24600031)
Statements
2 references
Activation of ERBB2 signaling causes resistance to the EGFR-directed therapeutic antibody cetuximab (English)
Marileila Varella-Garcia
Kimio Yonesaka
Kreshnik Zejnullahu
Isamu Okamoto
Taroh Satoh
John Souglakos
Dalia Ercan
Andrew Rogers
Masayuki Takeda
Yasuhito Fujisaka
Juliet Philips
Toshio Shimizu
Osamu Maenishi
Yonggon Cho
Jason Sun
Annarita Destro
Koichi Taira
Koji Takeda
Takafumi Okabe
Jeffrey Swanson
Hiroyuki Itoh
Minoru Takada
Eugene Lifshits
Kiyotaka Okuno
Jeffrey A Engelman
Ramesh A Shivdasani
Kazuto Nishio
Masahiro Fukuoka
Kazuhiko Nakagawa
Pasi A Jänne
1 September 2011
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
2 references
2 references
2 references